This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
RAN-Imipenem-Cilastatin (2015-12-23)
- Starting date:
- December 23, 2015
- Posting date:
- December 30, 2015
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-56486
Affected Products
RAN-Imipenem-Cilastatin
Reason
Out of specification result for an impurity during stability testing.
Depth of distribution
One wholesaler in Quebec distributing to hospitals.
Affected products
RAN-Imipenem-Cilastatin
DIN, NPN, DIN-HIM
DIN 02351692Dosage form
Powder for solution
Strength
Cilastatin (Cilastatin Sodium) 250mg/vial
Imipenem 250mg/vial
Lot or serial number
- 2686433
Companies
- Recalling Firm
-
Ranbaxy Pharmaceuticals Canada Inc.
126 East Drive
Brampton
L6T 1C1
CANADA
- Marketing Authorization Holder
-
Ranbaxy Pharmaceuticals Canada Inc.
126 East Drive
Brampton
L6T 1C1
CANADA